Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)
Close on Nov 17, 2026Market cap $88.39MP/E –Yield –
Stereotaxis total assets
Total assets on the balance sheet at the end of each period.
Stereotaxis's total assets was $55.58M at Jun 30, 2026. For fiscal 2025 it was $52.25M, up 11.8% from the year before. Over ten years it grew 10.7% a year on average. The highest annual figure on record is $65.76M in fiscal 2010.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.25M | +11.8% |
| FY2024 | Dec 31, 2024 | $46.72M | +11.5% |
| FY2023 | Dec 31, 2023 | $41.91M | -21.5% |
| FY2022 | Dec 31, 2022 | $53.41M | -12.4% |
| FY2021 | Dec 31, 2021 | $60.99M | +10.0% |
| FY2020 | Dec 31, 2020 | $55.46M | +27.2% |
| FY2019 | Dec 31, 2019 | $43.58M | +135.4% |
| FY2018 | Dec 31, 2018 | $18.51M | +73.6% |
| FY2017 | Dec 31, 2017 | $10.67M | -49.1% |
| FY2016 | Dec 31, 2016 | $20.97M | +11.1% |
| FY2015 | Dec 31, 2015 | $18.88M | -20.9% |
| FY2014 | Dec 31, 2014 | $23.88M | -23.2% |
| FY2013 | Dec 31, 2013 | $31.08M | -3.4% |
| FY2012 | Dec 31, 2012 | $32.17M | -19.4% |
| FY2011 | Dec 31, 2011 | $39.93M | -39.3% |
| FY2010 | Dec 31, 2010 | $65.76M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $55.58M | +35.0% |
| Q1 FY2026 | Mar 31, 2026 | $54.03M | +18.2% |
| Q4 FY2025 | Dec 31, 2025 | $52.25M | +11.8% |
| Q3 FY2025 | Sep 30, 2025 | $45.59M | -10.5% |
| Q2 FY2025 | Jun 30, 2025 | $41.17M | +14.3% |
| Q1 FY2025 | Mar 31, 2025 | $45.71M | +15.8% |
| Q4 FY2024 | Dec 31, 2024 | $46.72M | +11.5% |
| Q3 FY2024 | Sep 30, 2024 | $50.94M | +14.4% |
| Q2 FY2024 | Jun 30, 2024 | $36.01M | -25.5% |
| Q1 FY2024 | Mar 31, 2024 | $39.45M | -22.2% |
| Q4 FY2023 | Dec 31, 2023 | $41.91M | -21.5% |
| Q3 FY2023 | Sep 30, 2023 | $44.53M | -20.6% |
| Q2 FY2023 | Jun 30, 2023 | $48.32M | -14.8% |
| Q1 FY2023 | Mar 31, 2023 | $50.71M | -11.7% |
| Q4 FY2022 | Dec 31, 2022 | $53.41M | -12.4% |
| Q3 FY2022 | Sep 30, 2022 | $56.08M | -9.4% |
| Q2 FY2022 | Jun 30, 2022 | $56.68M | -1.1% |
| Q1 FY2022 | Mar 31, 2022 | $57.43M | -2.4% |
| Q4 FY2021 | Dec 31, 2021 | $60.99M | +10.0% |
| Q3 FY2021 | Sep 30, 2021 | $61.92M | +8.4% |
| Q2 FY2021 | Jun 30, 2021 | $57.34M | +0.5% |
| Q1 FY2021 | Mar 31, 2021 | $58.82M | +41.7% |
| Q4 FY2020 | Dec 31, 2020 | $55.46M | +27.2% |
| Q3 FY2020 | Sep 30, 2020 | $57.13M | +31.9% |
| Q2 FY2020 | Jun 30, 2020 | $57.05M | +168.4% |
| Q1 FY2020 | Mar 31, 2020 | $41.50M | +84.9% |
| Q4 FY2019 | Dec 31, 2019 | $43.58M | +135.4% |
| Q3 FY2019 | Sep 30, 2019 | $43.31M | +120.7% |
| Q2 FY2019 | Jun 30, 2019 | $21.26M | +6.4% |
| Q1 FY2019 | Mar 31, 2019 | $22.44M | +5.2% |
| Q4 FY2018 | Dec 31, 2018 | $18.51M | +73.6% |
| Q3 FY2018 | Sep 30, 2018 | $19.62M | +29.7% |
| Q2 FY2018 | Jun 30, 2018 | $19.97M | +19.7% |
| Q1 FY2018 | Mar 31, 2018 | $21.33M | +12.3% |
| Q4 FY2017 | Dec 31, 2017 | $10.67M | -49.1% |
| Q3 FY2017 | Sep 30, 2017 | $15.13M | -30.0% |
| Q2 FY2017 | Jun 30, 2017 | $16.68M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.99M | – |
| Q4 FY2016 | Dec 31, 2016 | $20.97M | – |
| Q3 FY2016 | Sep 30, 2016 | $21.60M | – |
See a number that looks wrong?